117 related articles for article (PubMed ID: 17925059)
1. ST2472: a new potential antipsychotic with very low liability to induce side-effects.
Stasi MA; Di Serio S; Vertechy M; Schiavone A; Ghirardi O; Minetti P; Campiani G; Borsini F; Carminati P
Int J Neuropsychopharmacol; 2008 May; 11(3):309-19. PubMed ID: 17925059
[TBL] [Abstract][Full Text] [Related]
2. Effects of ST2472, a novel antipsychotic, on prepulse inhibition.
Lombardo K; Stasi MA; Borsini F
Eur J Pharmacol; 2009 Oct; 621(1-3):53-60. PubMed ID: 19737551
[TBL] [Abstract][Full Text] [Related]
3. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Siuciak JA; Chapin DS; McCarthy SA; Guanowsky V; Brown J; Chiang P; Marala R; Patterson T; Seymour PA; Swick A; Iredale PA
Neuropharmacology; 2007 Feb; 52(2):279-90. PubMed ID: 16949622
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
Marchese G; Casu G; Casti P; Spada GP; Pani L
Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
[TBL] [Abstract][Full Text] [Related]
6. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.
Amato D; Stasi MA; Borsini F; Nencini P
Psychopharmacology (Berl); 2008 Oct; 200(2):157-65. PubMed ID: 18597076
[TBL] [Abstract][Full Text] [Related]
9. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
[TBL] [Abstract][Full Text] [Related]
10. Effect of muscarinic receptor agonists on animal models of psychosis.
Karan RS; Ravishankar P; Pandhi P
Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):169-72. PubMed ID: 10893700
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
Siuciak JA; Chapin DS; McCarthy SA; Martin AN
Psychopharmacology (Berl); 2007 Jun; 192(3):415-24. PubMed ID: 17333137
[TBL] [Abstract][Full Text] [Related]
12. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
13. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability.
Hoffman DC; Donovan H
Psychopharmacology (Berl); 1995 Jul; 120(2):128-33. PubMed ID: 7480543
[TBL] [Abstract][Full Text] [Related]
14. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
[TBL] [Abstract][Full Text] [Related]
15. The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
Boulay D; Bergis O; Avenet P; Griebel G
Neuropsychopharmacology; 2010 Jan; 35(2):416-27. PubMed ID: 19759529
[TBL] [Abstract][Full Text] [Related]
16. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
18. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
Cook L; Tam SW; Rohrbach KW
J Pharmacol Exp Ther; 1992 Dec; 263(3):1159-66. PubMed ID: 1361571
[TBL] [Abstract][Full Text] [Related]
19. 1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects.
Rigdon GC; Norman MH; Cooper BR; Howard JL; Boncek VM; Faison WL; Nanry KP; Pollard GT
Neuropsychopharmacology; 1996 Sep; 15(3):231-42. PubMed ID: 8873106
[TBL] [Abstract][Full Text] [Related]
20. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.
Tang AH; Franklin SR; Himes CS; Smith MW; Tenbrink RE
J Pharmacol Exp Ther; 1997 Apr; 281(1):440-7. PubMed ID: 9103528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
